142 related articles for article (PubMed ID: 14967602)
1. Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs.
Wang L; Zhu DM; Su X; Bai CX; Ware LB; Matthay MA
Exp Lung Res; 2004; 30(1):31-42. PubMed ID: 14967602
[TBL] [Abstract][Full Text] [Related]
2. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
Hedelin P; Kylhammar D; Rådegran G
Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
[TBL] [Abstract][Full Text] [Related]
3. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
[TBL] [Abstract][Full Text] [Related]
4. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
[TBL] [Abstract][Full Text] [Related]
5. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
Lundgren J; Kylhammar D; Hedelin P; Rådegran G
Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
[TBL] [Abstract][Full Text] [Related]
6. Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration.
Geiger R; Pajk W; Neu N; Maier S; Kleinsasser A; Fratz S; Navarro-Psiha S; Fischer V; Treml B; Loeckinger A
Pediatr Res; 2006 Jan; 59(1):147-50. PubMed ID: 16327003
[TBL] [Abstract][Full Text] [Related]
7. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury.
Persson BP; Rossi P; Weitzberg E; Oldner A
Shock; 2009 Oct; 32(4):427-34. PubMed ID: 19197226
[TBL] [Abstract][Full Text] [Related]
8. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock.
Somell A; Weitzberg E; Suneson A; Sollevi A; Hjelmqvist H
Acta Physiol (Oxf); 2007 Aug; 190(4):291-302. PubMed ID: 17498196
[TBL] [Abstract][Full Text] [Related]
9. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E
Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
[TBL] [Abstract][Full Text] [Related]
10. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
Chin A; Radhakrishnan J; Fornell L; John E
J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
[TBL] [Abstract][Full Text] [Related]
11. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets during endotoxic shock.
Chin A; Radhakrishnan J; Fornell L; John E
J Pediatr Surg; 2002 Mar; 37(3):482-7. PubMed ID: 11877672
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension.
Lourenço AP; Vasques-Nóvoa F; Oliveira-Pinto J; Fontoura D; Roncon-Albuquerque R; Leite-Moreira AF
Intensive Care Med; 2012 Jun; 38(6):1050-60. PubMed ID: 22349420
[TBL] [Abstract][Full Text] [Related]
13. Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange.
Rossi P; Wanecek M; Konrad D; Oldner A
Shock; 2004 Jun; 21(6):543-8. PubMed ID: 15167683
[TBL] [Abstract][Full Text] [Related]
14. The effect of tezosentan, a non-selective endothelin receptor antagonist, on shear stress-induced changes in arterial diameter of the anaesthetized dog.
Markos F; Hennessy BA; Fitzpatrick M; O'Sullivan J; Snow HM
J Physiol; 2002 Nov; 544(3):913-8. PubMed ID: 12411533
[TBL] [Abstract][Full Text] [Related]
15. Intravenous tezosentan and vardenafil attenuate acute hypoxic pulmonary hypertension.
Geiger R; Treml B; Kleinsasser A; Neu N; Fischer V; Stein JI; Loeckinger A
High Alt Med Biol; 2008; 9(3):223-7. PubMed ID: 18800959
[TBL] [Abstract][Full Text] [Related]
16. Effects of endothelin receptor antagonism on acute lung injury induced by chlorine gas.
Wang J; Oldner A; Winskog C; Edston E; Walther SM
Crit Care Med; 2006 Jun; 34(6):1731-7. PubMed ID: 16625121
[TBL] [Abstract][Full Text] [Related]
17. Tezosentan, another selective selection for pulmonary hypertension, or not?
Lorts A; Shanley TP
Pediatr Crit Care Med; 2004 Nov; 5(6):586-8. PubMed ID: 15540040
[No Abstract] [Full Text] [Related]
18. Effect of inhaled nitric oxide on pulmonary hemodynamics after acute lung injury in dogs.
Romand JA; Pinsky MR; Firestone L; Zar HA; Lancaster JR
J Appl Physiol (1985); 1994 Mar; 76(3):1356-62. PubMed ID: 7911801
[TBL] [Abstract][Full Text] [Related]
19. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
20. Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system.
Walweel K; Skeggs K; Boon AC; See Hoe LE; Bouquet M; Obonyo NG; Pedersen SE; Diab SD; Passmore MR; Hyslop K; Wood ES; Reid J; Colombo SM; Bartnikowski NJ; Wells MA; Black D; Pimenta LP; Stevenson AK; Bisht K; Marshall L; Prabhu DA; James L; Platts DG; Macdonald PS; McGiffin DC; Suen JY; Fraser JF
J Biomed Sci; 2020 Oct; 27(1):96. PubMed ID: 33008372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
